First author

1. Kawasaki D, Nakata A, Nishian K, Nishimura M, Fujiwara R, Nakata T, Fukunaga M. Impact of Peak Systolic Velocity Ratio after Drug-Coated Balloon for Femoropopliteal Disease: Three-Month Serial Observation Vessel Echo Study. J Atheroscler Thromb. 2022;29:1352-1358.
2. Kawasaki D, Yamada T, Fukunaga M. Feasibility and Safety of the Direct Occluded Vessel Puncture Technique as a New Access Site for Complex Peripheral Artery Occlusive Disease. J Atheroscler Thromb. 2021;28:349-355.
3. Kawasaki D, Fukunaga M, Nakata T, Kato M, Ohkubo N. Comparison of the OUTBACK® Elite Reentry Catheter and the Bi-directional Approach after Failed Antegrade Approach for Femoro-popliteal Occlusive Disease. J Atheroscler Thromb. 2017;24:1242-1248.
4. Kawasaki D, Fujii K, Fukunaga M, Fukuda N, Masuyama T, Ohkubo N, Kato M. Safety and efficacy of carbon dioxide and intravascular ultrasound-guided stenting for renal artery stenosis in patients with chronic renal insufficiency. Angiology. 2015;66:231-6.
5. Kawasaki D, Iida O, Fukunaga M, Kato M, Ohkubo N. Wire Passages of 0.035-inch Looped Wire Technique for Femoropopliteal Long Total Occlusions. J Atheroscler Thromb. 2015;22:1071-9.
6. Kawasaki D. A simple homemade carbon dioxide delivery system for endovascular procedures in the iliofemoral arteries-reply. Circ J. 2013;77:832.
7. Kawasaki D, Fujii K, Fukunaga M, Masutani M, Nakata A, Masuyama T. Safety and efficacy of endovascular therapy with a simple homemade carbon dioxide delivery system in patients with ileofemoral artery diseases. Circ J. 2012;76:1722-8.
8. Kawasaki D, Fujii K, Fukunaga M, Fujii N, Masutani M, Kawabata ML, Tsujino T, Ohyanagi M, Masuyama T. Preprocedural evaluation and endovascular treatment of iliofemoral artery disease without contrast media for patients with pre-existing renal insufficiency. Circ J. 2011;75:179-84.
9. Kawasaki D, Tsujino T, Fujii K, Masutani M, Ohyanagi M, Masuyama T. Novel use of ultrasound guidance for recanalization of iliac, femoral, and popliteal arteries. Catheter Cardiovasc Interv. 2008;71:727-33.
10. Kawasaki D, Kosugi K, Waki H, Yamamoto K, Tsujino T, Masuyama T. Role of activated renin-angiotensin system in myocardial fibrosis and left ventricular diastolic dysfunction in diabetic patients--reversal by chronic angiotensin II type 1A receptor blockade. Circ J. 2007;71:524-9.
11. Kawasaki D, Tsujino T, Morimoto S, Masai M, Masutani M, Ohyanagi M, Kashiwamura S, Okamura H, Masuyama T. Plasma interleukin-18 concentration: a novel marker of myocardial ischemia rather than necrosis in humans. Coron Artery Dis. 2005;16:437-41.
12. Kawasaki D, Tsujino T, Morimoto S, Fujioka Y, Naito Y, Okumura T, Masutani M, Shimizu H, Yuba M, Ueda A, Ohyanagi M, Kashiwamura S, Okamura H, Iwasaki T. Usefulness of circulating interleukin-18 concentration in acute myocardial infarction as a risk factor for late restenosis after emergency coronary angioplasty. Am J Cardiol. 2003;91:1258-61.

 

Co-author

1. Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, Yamauchi Y, Tobita K, Kozuki A, Fujihara M, Ando K; POPCORN Investigators. Vessel Patency and Associated Factors of Drug-Coated Balloon for Femoropopliteal Lesion. J Am Heart Assoc. 2023;12:e025677.
2. Takahara M, Soga Y, Fujihara M, Iida O, Kawasaki D. Association of Smoking, Diabetes, and Dialysis with the Presence of Popliteal Lesions in Femoropopliteal Artery Disease. J Atheroscler Thromb. 2022 (Epub ahead of print.)
3. Kawarada O, Zen K, Hozawa K, Obara H, Matsubara K, Yamamoto Y, Doijiri T, Tamai N, Ito S, Higashimori A, Kawasaki D, Doi H, Matsushita K, Tsukahara K, Noda K, Shimpo M, Tsuda Y, Sonoda S, Taniguchi T, Waseda K, Munehisa M, Taguchi E, Kinjo T, Sasaki Y, Yuba K, Yamaguchi S, Nakagami T, Ayabe S, Sakamoto S, Yagyu T, Ogata S, Nishimura K, Motomura H, Noguchi T, Ishihara M, Ogawa H, Yasuda S. Characteristics, Antithrombotic Patterns, and Prognostic Outcomes in Claudication and Critical Limb-Threatening Ischemia Undergoing Endovascular Therapy. J Endovasc Ther. 2022 (Epub ahead of print.)
4. Iida O, Soga Y, Seki SI, Kawasaki D, Anzai H, Ando H, Nakama T, Shinozaki N, Kozuki A, Ishihara M, Urasawa K, Toi S, Tsujita H, Tobita K, Ogata K, Horie K, Hayakawa N, Mori S, Fujihara M, Ohki T, Yuba K, Mano T, Nakamura M; TCD-17187 Japan Investigators. Twelve-month safety and effectiveness of TCD-17187 drug-coated balloon for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery. Catheter Cardiovasc Interv. 2022;100:1100-1109.
5. Soga Y, Takahara M, Iida O, Suzuki K, Mori S, Kawasaki D, Haraguchi K, Yamaoka T, Ando K. Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease. J Atheroscler Thromb. 2022;29:1448-1457.
6. Mochidome T, Takahara M, Miura T, Soga Y, Fujihara M, Kawasaki D, Hirano K, Choi D, Iida O. Vascular Pathology and Impact of Stent Eccentricity for Stent Restenosis in Femoropopliteal Endovascular Therapy. J Vasc Interv Radiol. 2022;33:1089-1096.
7. Tsujimura T, Iida O, Takahara M, Soga Y, Yamaoka T, Fujihara M, Kawasaki D, Ichihashi S, Kozuki A, Nanto S, Sakata Y, Mano T; CAPSICUM Investigators. Clinical Impact of Intravascular Ultrasound-Guided Fluoropolymer-Based Drug-Eluting Stent Implantation for Femoropopliteal Lesions. JACC Cardiovasc Interv. 2022;15:1569-1578.
8. Hata Y, Iida O, Katsuki T, Soga Y, Fukunaga M, Kawasaki D, Fujihara M, Takahara M, Inoue K, Mano T. Similar one-year primary patency rates of common femoral artery angioplasty alone when performed utilizing drug-coated versus noncoated balloons for the treatment of peripheral artery disease. Vasc Med. 2022 Au;27:380-381.
9. Higashino N, Iida O, Soga Y, Takahara M, Suzuki K, Mori S, Kawasaki D, Haraguchi K, Yamaoka T, Mano T. 10-Year clinical outcomes of hemodialysis patients with peripheral arterial disease due to infrainguinal disease undergoing endovascular therapy. Heart Vessels. 2022;37:1453-1461.
10. Fujiwara S, Kawasaki D, Sueyoshi K, Hisamoto H, Endo T. Gold Nanocone Array with Extensive Electromagnetic Fields for Highly Reproducible Surface-Enhanced Raman Scattering Measurements. Micromachines (Basel). 2022;13:1182.
11. Nakama T, Takahara M, Iwata Y, Fujimura N, Yamaoka T, Suzuki K, Obunai K; CAULIFLOWER Study Investigators. 1-Year Outcomes of Thromboendarterectomy vs Endovascular Therapy for Common Femoral Artery Lesions: CAULIFLOWER Study Results. JACC Cardiovasc Interv. 2022;15:1453-1463.
12. Nakamura R, Torii S, Kato T, Kawasaki D. A Case of Vasculitis Due to Distal Particulate Embolization After Use of Drug-Coated Balloon. JACC Cardiovasc Interv. 2022;15:1486-1487.
13. Yamauchi Y, Takahara M, Iida O, Shintani Y, Sugano T, Yamamoto Y, Kawasaki D, Fujihara M, Soga Y, Hirano K, Yamaguchi T, Yokoi H, Miyamoto A, Nakamura M; OMOTENASHI Investigators. Independent Predictors of Major Adverse Cardiovascular Events at 3 Years after Aortoiliac Stent Implantation. J Vasc Interv Radiol. 2022;33:826-833.e1.
14. Nakata A, Fukunaga M, Kawasaki D. The impact of plaque morphology in patients with peripheral artery disease on vessel dissection: an intravascular ultrasound observational study. Heart Vessels. 2022;37:961-968.
15. Iida O, Takahara M, Soga Y, Fujihara M, Kawasaki D, Hirano K, Choi D, Mano T. Vessel Diameter Evaluated by Intravascular Ultrasound Versus Angiography. J Endovasc Ther. 2022;29:343-349.
16. Kodama A, Takahara M, Iida O, Soga Y, Terashi H, Kawasaki D, Izumi Y, Mii S, Komori K, Azuma N. Ambulatory Status Over Time after Revascularization in Patients with Chronic Limb-Threatening Ischemia. J Atheroscler Thromb. 2022;29:866-880.
17. Soga Y, Fujihara M, Yamamoto Y, Nakamura S, Iida O, Kawasaki D, Urasawa K, Ando H, Mori S, Suzuki K, Horie K, Diaz-Cartelle J, Kozuki A. One-year results for Japanese patients in RANGER II SFA. Heart Vessels. 2022;37:568-573.
18. Takahara M, Soga Y, Fujihara M, Kawasaki D, Kozuki A, Iida O. Association of Age with Mortality Rate after Femoropopliteal Endovascular Therapy for Intermittent Claudication. J Atheroscler Thromb. 2022;29:474-481.
19. Iida O, Takahara M, Soga Y, Yamaoka T, Fujihara M, Kawasaki D, Ichihashi S, Kozuki A, Nanto S, Sakata Y, Mano T; CAPSICUM Investigators. 1-Year Outcomes of Fluoropolymer-Based Drug-Eluting Stent in Femoropopliteal Practice: Predictors of Restenosis and Aneurysmal Degeneration. JACC Cardiovasc Interv. 2022;15:630-638.
20. Kadoya Y, Zen K, Iida O, Yamamoto Y, Kawasaki D, Yamauchi Y, Shintani Y, Sugano T, Yokoi H, Matoba S, Nakamura M. Thrombotic Lesions are Associated with Poor Outcomes after Endovascular Treatment in Patients with Non-Acute Aortoiliac Total Occlusions. J Atheroscler Thromb. 2021;28:1323-1332.
21. Soga Y, Iida O, Fujihara M, Kawasaki D, Saito S, Urasawa K, Yokoi H, Fernandez EJ, Guo J, Nakamura M; IN.PACT Japan Post-Market Surveillance Study. Real-World Clinical Outcomes of IN.PACT Admiral Drug-Coated Balloon for Femoropopliteal Artery Disease　- 12-Month Results From Japan Post-Market Surveillance Study. Circ J. 2021;85:2149-2156.
22. Tomoi Y, Takahara M, Soga Y, Fujihara M, Iida O, Kawasaki D, Kozuki A, Ando K. Prognostic Value of the CHA2DS2-VASc Score after Endovascular Therapy for Femoral Popliteal Artery Lesions. J Atheroscler Thromb. 2021;28:1153-1160.
23. Tomoi Y, Takahara M, Kuramitsu S, Soga Y, Iida O, Fujihara M, Kawasaki D, Ando K; IVORY Study Investigators. Subintimal Versus Intraluminal Approach for Femoropopliteal Chronic Total Occlusions Treated With Intravascular Ultrasound Guidance. J Am Heart Assoc. 2021;10:e021903.
24. Hata Y, Iida O, Ito N, Soga Y, Fukunaga M, Kawasaki D, Fujihara M, Kozuki A, Takahara M, Mano T. Roles of Angioplasty With Drug-Coated Balloon for Chronic Ischemia in Wound Healing. J Endovasc Ther. 2021;28:778-787.
25. Iida O, Fujihara M, Kawasaki D, Mori S, Yokoi H, Miyamoto A, Kichikawa K, Nakamura M, Ohki T, Diaz-Cartelle J, Müller-Hülsbeck S, Gray WA, Soga Y. 24-Month Efficacy and Safety Results from Japanese Patients in the IMPERIAL Randomized Study of the Eluvia Drug-Eluting Stent and the Zilver PTX Drug-Coated Stent. Cardiovasc Intervent Radiol. 2021;44:1367-1374.
26. Katsuki T, Yamaji K, Soga Y, Iida O, Fujihara M, Kawasaki D, Ando K. New lesion after endovascular therapy of femoropopliteal lesions for intermittent claudication. Catheter Cardiovasc Interv. 2021;98:E395-E402.
27. Tsujimura T, Takahara M, Iida O, Soga Y, Katsuki T, Fujihara M, Kawasaki D, Kozuki A, Mano T. Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions. J Vasc Surg. 2021;73:1998-2008.e1.
28. Takahara M, Soga Y, Fujihara M, Kawasaki D, Kozuki A, Iida O. Inverse association of diabetes and dialysis with the severity of femoropopliteal lesions and chronic total occlusion: a cross-sectional study of 2056 cases. BMC Cardiovasc Disord. 2020;20:514.
29. Tsujimura T, Takahara M, Iida O, Yamauchi Y, Shintani Y, Sugano T, Yamamoto Y, Kawasaki D, Yokoi H, Miyamoto A, Mano T, Nakamura M. Intravascular Ultrasound Imaging During Aortoiliac Stenting: No Impact on Outcomes at 1 Year. J Endovasc Ther. 2021;28:139-145.
30. Iida O, Takahara M, Soga Y, Fujihara M, Kawasaki D, Hirano K, Choi D, Mano T. A Novel Angiographic Risk Score for Femoropopliteal Interventions. J Endovasc Ther. 2020;27:967-973.
31. Yamada T, Kawasaki D. Direct occluded vessel puncture technique as a new access site for complex peripheral artery occlusive disease. J Cardiol Cases. 2020;22:163-165.
32. Yamauchi Y, Takahara M, Shintani Y, Iida O, Sugano T, Yamamoto Y, Kawasaki D, Fujihara M, Hirano K, Soga Y, Tsubakimoto Y, Yokoi H, Miyamoto A, Nakamura M. Three-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions. Circ Cardiovasc Interv. 2020;13:e009168.
33. Fukunaga M, Fujii K, Mintz GS, Kawasaki D, Nakata T, Miki K, Imanaka T, Tamaru H, Shibuya M, Masuyama T. Distribution of pressure gradients along the left anterior descending artery in patients with angiographically normal arteries. Catheter Cardiovasc Interv. 2020;96:E67-E74.
34. Iida O, Takahara M, Yamauchi Y, Shintani Y, Sugano T, Yamamoto Y, Kawasaki D, Yokoi H, Miyamoto A, Mano T, Nakamura M; OMOTENASHI investigators. Impact of Hospital Volume on Clinical Outcomes after Aortoiliac Stenting in Patients with Peripheral Artery Disease. J Atheroscler Thromb. 2020;27:516-523.
35. Yamauchi Y, Takahara M, Iida O, Shintani Y, Sugano T, Yamamoto Y, Kawasaki D, Fujihara M, Soga Y, Hirano K, Yokoi H, Miyamoto A, Nakamura M; OMOTENASHI investigators. Independent predictors of loss of primary patency at 1 year after aortoiliac stent implantation. Heart Vessels. 2020;35:614-619.
36. Suzuki K, Iida O, Yamauchi Y, Nakano M, Soga Y, Kawasaki D, Tazaki J, Yamaoka T, Suematsu N, Shintani Y, Miyashita Y, Inoue N, Meguro T. Impact of Diabetes Mellitus on Critical Limb Ischemia With Below the Knee Disease: Japan Below-the-Knee Artery Treatment Subanalysis. Angiology. 2020;71:444-451.
37. Fukunaga M, Fujii K, Takahara M, Fujihara M, Utsunomiya M, Sasaki S, Tsubakimoto Y, Shiraki T, Inoue T, Aihara H, Iwasaki Y, Azuma K, Nakata T, Iida O, Yokoi H, Yokoi Y, Kawasaki D. Assessment of Microvasculature After Intervention as a Predictor of Wound Healing in Patients With Tissue Loss. JACC Cardiovasc Interv. 2020;13:976-985.
38. Golzar J, Soga Y, Babaev A, Iida O, Kawasaki D, Bachinsky W, Park J, Prem JT, Vermassen F, Diaz-Cartelle J, Müller-Hülsbeck S, Gray WA. Effectiveness and Safety of a Paclitaxel-Eluting Stent for Superficial Femoral Artery Lesions up to 190 mm: One-Year Outcomes of the Single-Arm IMPERIAL Long Lesion Substudy of the Eluvia Drug-Eluting Stent. J Endovasc Ther. 2020;27:296-303.
39. Tomoi Y, Kuramitsu S, Soga Y, Fujihara M, Iida O, Kawasaki D, Ando K. Vascular Response After FP-PES Versus Polymer-Free Paclitaxel-Eluting Stent Implantation in Femoropopliteal Artery Lesions: A Serial Intravascular Ultrasound Study. JACC Cardiovasc Interv. 2020;13:535-537.
40. Soga Y, Fujihara M, Iida O, Kawasaki D, Hirano K, Yokoi H, Miyamoto A, Kichikawa K, Nakamura M, Ohki T, Diaz-Cartelle J, Gray WA, Müller-Hülsbeck S. Japanese Patients Treated in the IMPERIAL Randomized Trial Comparing Eluvia and Zilver PTX Stents. Cardiovasc Intervent Radiol. 2020;43:215-222.
41. Soga Y, Fujihara M, Tomoi Y, Iida O, Ishihara T, Kawasaki D, Ando K. One-Year Late Lumen Loss between A Polymer-Coated Paclitaxel-Eluting Stent (Eluvia) and a Polymer-Free Paclitaxel-Coated Stent (Zilver PTX) for Femoropopliteal Disease. J Atheroscler Thromb. 2020;27:164-171.
42. Katsuki T, Takahara M, Soga Y, Okamoto S, Iida O, Fujihara M,Kawasaki D, Ando K. Mortality Risk Following Application of a Paclitaxel-Coated Stent in Femoropopliteal Lesions. J Endovasc Ther. 2019;26:593-599.
43. Tomoi Y, Soga Y, Takahara M, Fujihara M, Iida O, Kawasaki D, Ando K. Spot stenting versus full coverage stenting after endovascular therapy for femoropopliteal artery lesions. J Vasc Surg. 2019;70:1166-1176.
44. Kato T, Zen K, Kawarada O, Hozawa K, Anzai H, Nakamura H, Funatsu A, Kawasaki D, Tsubakimoto Y, Higashimori A, Kozuki A, Matoba S. Clinical outcomes of endovascular treatment for chronic aortic occlusion: a retrospective multicentre registry: EVT for chronic aortic occlusion. AsiaIntervention. 2019;5:121-127.
45. Takahara M, Iida O, Soga Y, Kawasaki D, Fujihara M. Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive. Cardiovasc Interv Ther. 2019;34:194-195.
46. Fukunaga M, Kawasaki D, Nishimura M, Yamagami M, Fujiwara R, Nakata T. Clinical Effects of Planned Endovascular Therapy for Critical Limb Ischemia Patients with Tissue Loss. J Atheroscler Thromb. 2019;26:294-301.
47. Karashima E, Kawasaki D, Yoda S, Yasuda S, Kaneko T. Protrusion of a loop-shaped 0.035-inch wire without the fracture of the self-expanding nitinol stent: A case report and experimental study. Clin Case Rep. 2019;7:357-360.
48. Yamauchi Y, Takahara M, Shintani Y, Iida O, Sugano T, Yamamoto Y, Kawasaki D, Fujihara M, Hirano K, Yokoi H, Miyamoto A, Nakamura M; OMOTENASHI investigators. One-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions. Circ Cardiovasc Interv. 2019;12:e007441.
49. Higashimori A, Takahara M, Utsunomiya M, Fukunaga M, Kawasaki D, Mori S, Takimura H, Hirano K, Tsubakimoto Y, Nakama T, Yokoi Y. Utility of indigo carmine angiography in patients with critical limb ischemia: Prospective multi-center intervention study (DIESEL-study). Catheter Cardiovasc Interv. 2019;93:108-112.
50. Tokuda T, Hirano K, Soga Y, Iida O, Kawasaki D, Yamauchi Y, Suzuki K, Kamoi D, Tazaki J. Comparison of 3-year clinical outcomes after endovascular therapy for aortoiliac artery occlusive disease between patients with and without hemodialysis: Subanalysis of the REAL-AI registry. Catheter Cardiovasc Interv. 2018;92:1345-1351.
51. Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, Schroeder H, Prem JT, Holden A, Popma J, Jaff MR, Diaz-Cartelle J, Müller-Hülsbeck S; IMPERIAL investigators. A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial. Lancet. 2018;392:1541-1551.
52. Soga Y, Hamasaki T, Edahiro R, Iida O, Inoue N, Suzuki K, Yokoi Y, Kawasaki D, Zen K, Urasawa K, Aodo K; STOP-IC investigators. Sustained Effectiveness of Cilostazol After Endovascular Treatment of Femoropopliteal Lesions: Midterm Follow-up From the Sufficient Treatment of Peripheral Intervention by Cilostazol (STOP-IC) Study. J Endovasc Ther. 2018;25:306-312.
53. Kamioka N, Soga Y, Kuramitsu S, Iida O, Hirano K, Suzuki K, Kawasaki D, Yamaoka T, Suematsu N, Shintani Y, Miyashita Y, Takahashi H, Tsuchiya T, Shinozaki N, Okazaki S, Ando K. Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL-FP). Catheter Cardiovasc Interv. 2017;90:790-797.
54. Hiramori S, Soga Y, Iida O, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Ando K. Relationship between clinical outcomes and vessel size in endovascular therapy for femoropopliteal lesions. J Vasc Surg. 2017;65:1690-1697.
55. Zen K, Takahara M, Iida O, Soga Y, Kawasaki D, Nanto S, Yokoi H, Matoba S; ZEPHYR Investigators. Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease. J Vasc Surg. 2017;65:720-725.
56. Miki K, Fujii K, Kawasaki D, Shibuya M, Fukunaga M, Imanaka T, Tamaru H, Sumiyoshi A, Nishimura M, Horimatsu T, Saita T, Kobayashi Y, Honda Y, Fitzgerald PJ, Masuyama T, Ishihara M. Impact of analysis interval size on the quality of optical frequency domain imaging assessments of stent implantation for lesions of the superficial femoral artery. Catheter Cardiovasc Interv. 2017;89:735-745.
57. Utsunomiya M, Takahara M, Iida O, Yamauchi Y, Kawasaki D, Yokoi Y, Soga Y, Ohura N, Nakamura M; OLIVE Investigators. Wound Blush Obtainment Is the Most Important Angiographic Endpoint for Wound Healing. JACC Cardiovasc Interv. 2017;10:188-194.
58. Suzuki K, Mizutani Y, Soga Y, Iida O, Kawasaki D, Yamauchi Y, Hirano K, Koshida R, Kamoi D, Tazaki J, Higashitani M, Shintani Y, Yamaoka T, Okazaki S, Suematsu N, Tsuchiya T, Miyashita Y, Shinozaki N, Takahashi H, Inoue N. Efficacy and Safety of Endovascular Therapy for Aortoiliac TASC D Lesions. Angiology. 2017;68:67-73.
59. Iida O, Takahara M, Soga Y, Hirano K, Yamauchi Y, Zen K, Yokoi H, Uematsu M; ZEPHYR investigators. Incidence and its characteristics of repetition of reintervention after drug-eluting stent implantation for femoropopliteal lesion. J Vasc Surg. 2016;64:1691-1695.
60. Ishihara T, Takahara M, Iida O, Soga Y, Hirano K, Yamauchi Y, Zen K, Kawasaki D, Nanto S, Yokoi H, Uematsu M; ZEPHYR Investigators. Comparable 2-Year Restenosis Rates Following Subintimal and Intraluminal Drug-Eluting Stent Implantation for Femoropopliteal Chronic Total Occlusion. J Endovasc Ther. 2016;23:889-895.
61. Suzuki K, Takahara M, Shintani Y, Tanaka A, Soga Y, Yamaoka T, Tosaka A, Sasaki S, Kawasaki D, Tsuchiya T, Kozuki A, Iida O. Retrospective Multicenter Comparison of S.M.A.R.T. CONTROL and MISAGO Stents in Treatment of Femoropopliteal Lesions. J Vasc Interv Radiol. 2016;27:1642-1649.
62. Utsunomiya M, Iida O, Yamauchi Y, Nakano M, Soga Y, Kawasaki D, Takahara M, Nakamura M. Influence of Repeat Intervention on the Risk of Major Amputation After Infrapopliteal Angioplasty for Critical Limb Ischemia. J Endovasc Ther. 2016;23:710-6.
63. Nishimura M, Fujii K, Fukunaga M, Kawasaki D, Miki K, Saita T, Horimatsu T, Tamaru H, Imanaka T, Naito Y, Masuyama T. Chronic vascular response after self-expanding nitinol stent implantation in superficial femoral arteries: a serial intravascular ultrasound analysis. Cardiovasc Interv Ther. 2016;31:255-62.
64. Nakata T, Fujii K, Fukunaga M, Shibuya M, Kawai K, Kawasaki D, Naito Y, Ohyanagi M, Masuyama T. Morphological, Functional, and Biological Vascular Healing Response 6 Months After Drug-Eluting Stent Implantation: A Randomized Comparison of Three Drug-Eluting Stents. Catheter Cardiovasc Interv. 2016;88:350-7.
65. Murata N, Takahara M, Soga Y, Nakano M, Yamauchi Y, Zen K, Kawasaki D, Yokoi H, Tosaka A, Tanaka N, Iida O. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study. J Endovasc Ther. 2016;23:642-7.
66. Miki K, Fujii K, Kawasaki D, Shibuya M, Fukunaga M, Imanaka T, Tamaru H, Sumiyoshi A, Nishimura M, Horimatsu T, Saita T, Okada K, Kimura T, Honda Y, Fitzgerald PJ, Masuyama T, Ishihara M. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery. J Endovasc Ther. 2016;23:424-32.
67. Iida O, Takahara M, Soga Y, Hirano K, Yamauchi Y, Zen K, Kawasaki D, Nanto S, Yokoi H, Uematsu M; ZEPHYR Investigators. The Characteristics of In-Stent Restenosis After Drug-Eluting Stent Implantation in Femoropopliteal Lesions and 1-Year Prognosis After Repeat Endovascular Therapy for These Lesions. JACC Cardiovasc Interv. 2016;9:828-834.
68. Soga Y, Takahara M, Iida O, Nakano M, Yamauchi Y, Zen K, Kawasaki D, Ando K. Propensity Score Analysis Comparing Clinical Outcomes of Drug-Eluting vs Bare Nitinol Stents in Femoropopliteal Lesions. J Endovasc Ther. 2016;23:33-9.
69. Higashimori A, Iida O, Yamauchi Y, Kawasaki D, Nakamura M, Soga Y, Zen K, Yokoi Y; OLIVE Investigators. Outcomes of One straight-line flow with and without pedal arch in patients with critical limb ischemia. Catheter Cardiovasc Interv. 2016;87:129-33.
70. Soga Y, Takahara M, Iida O, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Yamaoka T, Ando K. Relationship Between Primary Patency and Lesion Length Following Bare Nitinol Stent Placement for Femoropopliteal Disease. J Endovasc Ther. 2015;22:862-7.
71. Shintani Y, Soga Y, Takahara M, Iida O, Kawasaki D, Yamauchi Y, Suzuki K, Hirano K, Kawasaki T. Clinical Outcomes of SMART Versus Luminexx Nitinol Stent Implantation for Aortoiliac Artery Disease: A Propensity Score-Matched Multicenter Study. Angiology. 2015;66:875-81.
72. Nanto K, Iida O, Takahara M, Soga Y, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Suematsu N, Yamaoka T, Uematsu M. Effect of Cilostazol Following Endovascular Intervention for Peripheral Artery Disease. Angiology. 2015;66:774-8.
73. Nakano M, Hirano K, Iida O, Yamauchi Y, Soga Y, Kawasaki D, Tazaki J, Suzuki K, Fujiwara M, Yamaoka T. Clinical efficacy of infrapopliteal endovascular procedures for hemodialysis patients with critical limb ischemia. Ann Vasc Surg. 2015;29:1225-34.
74. Nakano M, Hirano K, Yamauchi Y, Iida O, Soga Y, Kawasaki D, Yamaoka T, Suematsu N, Suzuki K. Three-year clinical outcome after infrapopliteal angioplasty for critical limb ischemia in hemodialysis patients with minor or major tissue loss. Catheter Cardiovasc Interv. 2015;86:289-98.
75. Iida O, Takahara M, Soga Y, Nakano M, Yamauchi Y, Zen K, Kawasaki D, Nanto S, Yokoi H, Uematsu M; ZEPHYR Investigators. 1-Year Results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): Predictors of Restenosis. JACC Cardiovasc Interv. 2015;8:1105-1112.
76. Tamaru H, Fujii K, Fukunaga M, Imanaka T, Miki K, Kawasaki D, Masutani M, Ohyanagi M, Masuyama T. Potential influence of invisible coronary collateral circulation on fractional flow reserve of donor artery in the presence of severe stenosis of receiving artery. Cardiovasc Interv Ther. 2015;30:266-9.
77. Fukunaga M, Fujii K, Kawasaki D, Nishimura M, Horimatsu T, Saita T, Miki K, Tamaru H, Imanaka T, Naito Y, Masuyama T. Vascular flow reserve immediately after infrapopliteal intervention as a predictor of wound healing in patients with foot tissue loss. Circ Cardiovasc Interv. 2015;8:e002412.
78. Shiraki T, Iida O, Takahara M, Soga Y, Yamauchi Y, Hirano K, Kawasaki D, Fujihara M, Utsunomiya M, Tazaki J, Yamaoka T, Shintani Y, Suematsu N, Suzuki K, Miyashita Y, Tsuchiya T, Uematsu M. Predictors of delayed wound healing after endovascular therapy of isolated infrapopliteal lesions underlying critical limb ischemia in patients with high prevalence of diabetes mellitus and hemodialysis. Eur J Vasc Endovasc Surg. 2015;49:565-73.
79. Fujihara M, Kawasaki D, Shintani Y, Fukunaga M, Nakama T, Koshida R, Higashimori A, Yokoi Y; CO2 Angiography Registry Investigators. Endovascular therapy by CO2 angiography to prevent contrast-induced nephropathy in patients with chronic kidney disease: a prospective multicenter trial of CO2 angiography registry. Catheter Cardiovasc Interv. 2015;85:870-7.
80. Murata N, Soga Y, Iida O, Yamauchi Y, Hirano K, Kawasaki D, Fujihara M, Tomoi Y. Complex relationship of body mass index with mortality in patients with critical limb ischemia undergoing endovascular treatment. Eur J Vasc Endovasc Surg. 2015;49:297-305.
81. Soga Y, Iida O, Takahara M, Hirano K, Suzuki K, Kawasaki D. Beta-blocker Treatment Does Not Worsen Critical Limb Ischemia in Patients Receiving Endovascular Therapy. J Atheroscler Thromb. 2015;22:481-9.
82. Suematsu N, Iida O, Takahara M, Yamauchi Y, Soga Y, Nakano M, Hirano K, Kawasaki D, Yamaoka T, Suzuki K, Shintani Y, Miyashita Y, Tazaki J, Meno H, Inou T. Prognostic Factors in Hemodialysis Patients Undergoing Endovascular Treatment for Critical Limb Ischemia due to Isolated Below-the-Knee Disease. J Atheroscler Thromb. 2015;22:404-14.
83. Soga Y, Iida O, Takahara M, Hirano K, Suzuki K, Kawasaki D, Miyashita Y, Tsuchiya T. Two-year life expectancy in patients with critical limb ischemia. JACC Cardiovasc Interv. 2014;7:1444-9.
84. Iida O, Takahara M, Soga Y, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Suematsu N, Yamaoka T, Nanto S, Uematsu M. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions. J Endovasc Ther. 2014;21:485-92.
85. Iida O, Takahara M, Soga Y, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Suematsu N, Yamaoka T, Nanto S, Uematsu M. Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery. JACC Cardiovasc Interv. 2014;7:792-8.
86. Miura T, Soga Y, Miyashita Y, Iida O, Kawasaki D, Hirano K, Suzuki K, Ikeda U. Five-year prognosis after endovascular therapy in claudicant patients with iliofemoral artery disease. J Endovasc Ther. 2014;21:381-8.
87. Soga Y, Mii S, Iida O, Okazaki J, Kuma S, Hirano K, Suzuki K, Kawasaki D, Yamaoka T, Kamoi D, Shintani Y. Propensity score analysis of clinical outcome after bypass surgery vs. endovascular therapy for infrainguinal artery disease in patients with critical limb ischemia. J Endovasc Ther. 2014;21:243-53.
88. Fukunaga M, Fujii K, Kawasaki D, Sawada H, Miki K, Tamaru H, Imanaka T, Iwasaku T, Nakata T, Shibuya M, Akahori H, Masutani M, Kobayashi K, Ohyanagi M, Masuyama T. Thermodilution-derived coronary blood flow pattern immediately after coronary intervention as a predictor of microcirculatory damage and midterm clinical outcomes in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv. 2014;7:149-55.
89. Iida O, Soga Y, Takahara M, Kawasaki D, Yamauchi Y, Suzuki K, Hirano K, Koshida R, Kamoi D, Tazaki J, Higashitani M, Shintani Y, Yamaoka T, Okazaki S, Suematsu N, Tsuchiya T, Miyashita Y, Shinozaki N, Takahashi H, Uematsu M. Perioperative complications after aorto-iliac stenting: associated factors and impact on follow-up cardiovascular prognosis. Eur J Vasc Endovasc Surg. 2014;47:131-8.
90. Miki K, Fujii K, Kawasaki D, Fukunaga M, Nishimura M, Horimatsu T, Saita T, Tamaru H, Imanaka T, Shibuya M, Masutani M, Ohyanagi M, Masuyama T. Effect of bare-metal nitinol stent implantation and paclitaxel-eluting nitinol stent implantation on vascular response in the superficial femoral artery lesion assessed on intravascular ultrasound. Circ J. 2014;78:1451-8.
91. Soga Y, Iida O, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Suematsu N, Yamaoka T, Tsuchiya T, Miyashita Y, Okazaki S, Shinozaki N, Takahashi H. Clinical impact of bisoprolol versus carvedilol in patients undergoing femoropopliteal stenting. J Atheroscler Thromb. 2014;21:691-702.
92. Imanaka T, Fujii K, Fukunaga M, Miki K, Kawasaki D, Tamaru H, Masutani M, Ohyanagi M, Masuyama T. A case of acute thrombotic occlusion of the popliteal artery occurring immediately after the total knee arthroplasty recanalized by ballooning alone. J Cardiol Cases. 2013;8:190-192.
93. Soga Y, Iida O, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Suematsu N, Yamaoka T. Initial and 3-year results after subintimal versus intraluminal approach for long femoropopliteal occlusion treated with a self-expandable nitinol stent. J Vasc Surg. 2013;58:1547-55.
94. Tomoi Y, Soga Y, Iida O, Hirano K, Suzuki K, Kawasaki D, Yamauchi Y, Miyashita Y, Tazaki J, Nobuyoshi M. Efficacy of statin treatment after endovascular therapy for isolated below-the-knee disease in patients with critical limb ischemia. Cardiovasc Interv Ther. 2013;28:374-82.
95. Iida O, Yokoi H, Soga Y, Inoue N, Suzuki K, Yokoi Y, Kawasaki D, Zen K, Urasawa K, Shintani Y, Miyamoto A, Hirano K, Miyashita Y, Tsuchiya T, Shinozaki N, Nakamura M, Isshiki T, Hamasaki T, Nanto S; STOP-IC investigators. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study. Circulation. 2013;127:2307-15.
96. Iida O, Soga Y, Takahara M, Kawasaki D, Yamauchi Y, Suzuki K, Hirano K, Ryoji K, Kamoi D, Tazaki J, Higashitani M, Shintani Y, Yamaoka T, Okazaki S, Suematsu N, Tsuchiya T, Miyashita Y, Shinozaki N, Takahashi H, Uematsu M. Efficacy of the S.M.A.R.T. Control vs. other stents for aortoiliac occlusive disease in contemporary clinical practice. J Endovasc Ther. 2013;20:431-9.
97. Iida O, Soga Y, Yamauchi Y, Hirano K, Kawasaki D, Yamaoka T, Takahara M, Uematsu M. Clinical efficacy of endovascular therapy for patients with critical limb ischemia attributable to pure isolated infrapopliteal lesions. J Vasc Surg. 2013;57:974-981.
98. Nakano M, Hirano K, Iida O, Soga Y, Kawasaki D, Suzuki K, Miyashita Y. Prognosis of critical limb ischemia in hemodialysis patients after isolated infrapopliteal balloon angioplasty: results from the Japan below-the-knee artery treatment (J-BEAT) registry. J Endovasc Ther. 2013;20:113-24.
99. Iida O, Nakamura M, Yamauchi Y, Kawasaki D, Yokoi Y, Yokoi H, Soga Y, Zen K, Hirano K, Suematsu N, Inoue N, Suzuki K, Shintani Y, Miyashita Y, Urasawa K, Kitano I, Yamaoka T, Murakami T, Uesugi M, Tsuchiya T, Shinke T, Oba Y, Ohura N, Hamasaki T, Nanto S; OLIVE Investigators. Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up. Circ Cardiovasc Interv. 2013;6:68-76.
100. Takahara M, Iida O, Soga Y, Hirano K, Yamaoka T, Kawasaki D, Suzuki K, Suematsu N, Shintani Y, Miyashita Y, Kaneto H, Shimomura I. Seasonal variation in critical limb ischemia requiring endovascular therapy: an analysis of a multicenter database of Japanese patients with critical limb ischemia undergoing endovascular therapy. J Atheroscler Thromb. 2013;20:726-32.
101. Miki K, Fujii K, Fukunaga M, Kawasaki D, Shibuya M, Imanaka T, Tamaru H, Masutani M, Ohyanagi M, Masuyama T. Impact of post-procedural intravascular ultrasound findings on long-term results following self-expanding nitinol stenting in superficial femoral artery lesions. Circ J. 2013;77:1543-50.
102. Fukunaga M, Fujii K, Nakata T, Shibuya M, Miki K, Kawasaki D, Masutani M, Kawabata-Lee M, Ohyanagi M, Masuyama T. Multiple complex coronary atherosclerosis in diabetic patients with acute myocardial infarction: a three-vessel optical coherence tomography study. EuroIntervention. 2012;8:955-61.
103. Soga Y, Iida O, Kawasaki D, Hirano K, Yamaoka T, Suzuki K. Impact of cilostazol on angiographic restenosis after balloon angioplasty for infrapopliteal artery disease in patients with critical limb ischemia. Eur J Vasc Endovasc Surg. 2012;44:577-81.
104. Iida O, Soga Y, Kawasaki D, Hirano K, Yamaoka T, Suzuki K, Miyashita Y, Yokoi H, Takahara M, Uematsu M. Angiographic restenosis and its clinical impact after infrapopliteal angioplasty. Eur J Vasc Endovasc Surg. 2012;44:425-31.
105. Miki K, Fujii K, Nakata T, Shibuya M, Fukunaga M, Kawai K, Kawasaki D, Masutani M, Ohyanagi M, Masuyama T. The utility of intravascular ultrasound for the diagnosis and management of spontaneous coronary artery dissection in a middle-aged woman with acute inferior myocardial infarction. J Cardiol Cases. 2012;6;e78-e80.
106. Iida O, Soga Y, Yamauchi Y, Hirano K, Kawasaki D, Tazaki J, Yamaoka T, Suematsu N, Suzuki K, Shintani Y, Miyashita Y, Takahara M, Uematsu M. Anatomical predictors of major adverse limb events after infrapopliteal angioplasty for patients with critical limb ischaemia due to pure isolated infrapopliteal lesions. Eur J Vasc Endovasc Surg. 2012;44:318-24.
107. Iida O, Soga Y, Hirano K, Kawasaki D, Suzuki K, Miyashita Y, Nanto S, Uematsu M. Midterm outcomes and risk stratification after endovascular therapy for patients with critical limb ischaemia due to isolated below-the-knee lesions. Eur J Vasc Endovasc Surg. 2012;43:313-21.
108. Iida O, Soga Y, Hirano K, Kawasaki D, Suzuki K, Miyashita Y, Terashi H, Uematsu M. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions. J Vasc Surg. 2012;55:363-370.
109. Soga Y, Iida O, Kawasaki D, Yamauchi Y, Suzuki K, Hirano K, Koshida R, Kamoi D, Tazaki J, Higashitani M, Shintani Y, Yamaoka T, Okazaki S, Suematsu N, Tsuchiya T, Miyashita Y, Shinozaki N, Takahashi H; REAL-AI investigators. Contemporary outcomes after endovascular treatment for aorto-iliac artery disease. Circ J. 2012;76:2697-704.
110. Soga Y, Iida O, Hirano K, Suzuki K, Kawasaki D, Miyashita Y, Tsuchiya T, Nobuyoshi M. Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemia. J Vasc Surg. 2011;54:1659-67.
111. Fujii K, Kawasaki D, Oka K, Akahori H, Fukunaga M, Sawada H, Masutani M, Lee-Kawabata M, Tsujino T, Ohyanagi M, Masuyama T. Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantation. Heart. 2011;97:977-82.
112. Fujii K, Kawasaki D, Oka K, Akahori H, Iwasaku T, Fukunaga M, Eguchi A, Sawada H, Masutani M, Lee-Kawabata M, Tsujino T, Ohyanagi M, Masuyama T. The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention. JACC Cardiovasc Interv. 2011;4:513-20.
113. Nakata T, Fujii K, Fukunaga M, Kawasaki D, Kawabata-Lee M, Masutani M, Ohyanagi M, Masuyama T. The impact of plaque characterization assessed by intravascular ultrasound on myocardial perfusion after primary angioplasty in patients With ST-segment elevation myocardial infarction. Circ J. 2011;75:2642-7.
114. Fujii K, Kawasaki D, Masutani M, Okumura T, Akagami T, Sakoda T, Tsujino T, Ohyanagi M, Masuyama T. OCT assessment of thin-cap fibroatheroma distribution in native coronary arteries. JACC Cardiovasc Imaging. 2010;3:168-75.
115. Fujii K, Masutani M, Okumura T, Kawasaki D, Akagami T, Ezumi A, Sakoda T, Masuyama T, Ohyanagi M. Frequency and predictor of coronary thin-cap fibroatheroma in patients with acute myocardial infarction and stable angina pectoris a 3-vessel optical coherence tomography study. J Am Coll Cardiol. 2008;52:787-8.
116. Tsujino T, Kawasaki D, Masuyama T. Left ventricular diastolic dysfunction in diabetic patients: pathophysiology and therapeutic implications. Am J Cardiovasc Drugs. 2006;6:219-30.
117. Tsujino T, Naito Y, Kawasaki D, Okuda S, Sakoda T, Fujioka Y, Sugaya T, Ohyanagi M. Circadian expression of plasminogen activator inhibitor-1 in angiotensin II type 1a receptor knockout mice. Clin Exp Hypertens. 2005;27:159-68.
118. Fujii K, Masutani M, Kobayashi Y, Tateishi J, Kawasaki D, Ohyanagi M, Mintz GS, Leon MB. Contribution of early lumen loss after balloon angioplasty for in-stent restenosis to lumen loss at follow-up. Catheter Cardiovasc Interv. 2004;63:52-6.
119. Naito Y, Tsujino T, Kawasaki D, Okumura T, Morimoto S, Masai M, Sakoda T, Fujioka Y, Ohyanagi M, Iwasaki T. Circadian gene expression of clock genes and plasminogen activator inhibitor-1 in heart and aorta of spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens. 2003;21:1107-15.
120. Makino S, Kawasaki D, Irimoto H, Tanimoto M. Late onset of adrenocortical failure in GH deficiency with invisible pituitary stalk: a case report of a 48-year-old Japanese man and review of the literature. Endocr J. 2002;49:231-40.